A Message From Professor Rudy Nuijts Monday May 18, 2020


Rudy Nuijts
Published: Tuesday, May 19, 2020
Dear Colleagues
As I write today in mid-May 2020, our governments are struggling to guide us on how to safely resume our personal and professional lives. Across Europe clinics closed to elective surgeries for two months are making careful plans to open, while ensuring measures are in place to keep themselves, their staff and their patients free from getting and spreading this virus.
This is a daunting task we face and there will surely be successes and failures along the way. Our colleagues in Italy, Slovenia and the UK share with us their plans for making clinics safe and strategies for dealing with the backlog of patients awaiting surgery. And our colleague Alvin Young in Hong Kong charts for us his experience of COVID-19.
Dr Sethuramam, in a JAMA viewpoint article, gives us an overview on testing for COVID-19 but, more optimistically, scientists at Imperial College London tell us they are trialling a test which could provide results in a little over a minute. If this test were successful and widely available, it would be transformative in managing our clinics in the time before a vaccine is available.
Stay safe and well

Rudy Nuijts
Prof. dr Rudy MMA Nuijts
ESCRS President

Latest Articles
ESCRS Today 2025: Happy Anniversaries!
ESCRS celebrates milestones with pioneers in IOLs, LASIK, femtosecond lasers, and corneal transplantation.
ESCRS Today 2025: A Congress for Everyone
From YOs to families, the ESCRS Annual Meeting embraces full participation through inclusivity.
Beyond the Numbers
Empowering patient participation fosters continuous innovation in cataract surgery.
Thinking Beyond the Surgery Room
Practice management workshop focuses on financial operations and AI business applications.
Aid Cuts Threaten Global Eye Care Progress
USAID closure leads retreat in development assistance.
Supplement: ESCRS Clinical Trends Series: Presbyopia
Debate: FS-LASIK or KLEx for Hyperopia?
FS-LASIK has more of a track record, but KLEx offers advantages.
Four AI Applications Ready for Practice
Commercial offerings may save time, improve practice and research.
Perioperative Medication Regimens for Cataract Surgery
Randomised controlled clinical trial results provide evidence-based guidance.